How have BLACR shares performed in 2024?

Bellevue Life Sciences Acquisition's stock was trading at $0.1499 at the beginning of 2024. Since then, BLACR shares have increased by 0.3% and is now trading at $0.1503. View the best growth stocks for 2024 here .

How do I buy shares of Bellevue Life Sciences Acquisition?

Shares of BLACR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BLACR

Bellevue Life Sciences Acquisition (BLACR) Stock Price, News & Analysis

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)

Free BLACR Stock Alerts

$0.15

+0.04 (+36.26%)

(As of 05/17/2024 ET)

Compare

Today's Range: $0.14
▼
$0.15
50-Day Range: $0.11
▼
$0.15
52-Week Range: $0.11
▼
$0.48

Volume: 903 shs
Average Volume: 7,055 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Social Media

Get Bellevue Life Sciences Acquisition alerts:

Ad Porter & Company

Elon to Transform U.S. Economy?

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

About Bellevue Life Sciences Acquisition

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

BLACR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BLACR Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BLACR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: --
Industry: -
Sub-Industry: N/A
Current Symbol: NASDAQ:BLACR
CUSIP: N/A
CIK: 1840425
Web: N/A
Phone: 425-635-7700
Fax: N/A
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Kuk Hyoun Hwang (Age 46)
CEO & Director
Mr. David Jin Yoo (Age 49)
Chief Financial Officer

Key Competitors

View All Competitors

BLACR Stock Analysis - Frequently Asked Questions

How have BLACR shares performed in 2024?: Bellevue Life Sciences Acquisition's stock was trading at $0.1499 at the beginning of 2024. Since then, BLACR shares have increased by 0.3% and is now trading at $0.1503.
View the best growth stocks for 2024 here.
How do I buy shares of Bellevue Life Sciences Acquisition?: Shares of BLACR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BLACR) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial